Influenza News and Research

Latest Influenza News and Research

New report on CEL-SCI's H1N1 flu drug candidate

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published a new report about CEL-SCI Corporation's new H1N1 flu drug candidate.

24 Sep 2009

H1N1 slows growth in US industries and GDP

H1N1 influenza could slow growth in key industries and stall already-weak GDP growth in the third and fourth quarters of 2009, says a health economist in the University of Alabama at Birmingham (UAB) School of Business.

24 Sep 2009

Pregnant women must be vaccinated against H1N1 and seasonal flu

Pregnant women should be sure to get all their flu shots as soon as the vaccines become available this year to protect them against both the seasonal flu and the H1N1 (swine) flu, according to eight leading national maternal and infant health organizations.

24 Sep 2009

Global effort needed to protect people from species-crossing diseases, Report finds

A team of health experts on Tuesday called for the U.S. "to lead a global effort to protect people from new outbreaks of deadly infectious diseases that originate in animals, such as swine flu, AIDS and SARS," Reuters writes (Morgan, 9/22).

24 Sep 2009

Study of new swine flu vaccines looks for local children to take part

Paediatricians at Bristol Children's Vaccine Centre are looking for 170 children to take part in a study of the two swine 'flu vaccines due to be used in the UK this winter.

23 Sep 2009

Report outlining global weaknesses in preventing deadly diseases

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.

23 Sep 2009

Report on species-crossing microbes and H1N1

23 Sep 2009

Axion Health and CHS to deliver Workforce Emergency Preparedness and Response programs

Axion HealthTM (www.axionhealth.com), a workforce health protection, emergency preparedness and response provider, today announced that it will partner with Comprehensive Health Services, Inc. (www.chsmedical.com), the industry’s largest independent provider of onsite health centers, nationwide exam programs and rapid response medical readiness teams for workforce health to deliver its ReadySetTM Program for Workforce Emergency Preparedness and Response; including the ReadySet Pandemic Program for prevention, protection and response to pandemic health threats.

23 Sep 2009

Children’s Hospital offers tips on H1N1 and seasonal flu

With the early onset of flu season coinciding with the start of school this year, parents are concerned about the flu. Experts from The Children’s Hospital in Denver, Colo., offer a pediatric perspective on all types of flu, including H1N1, also known as swine flu.

23 Sep 2009

Sanofi Pasteur receives additional order H1N1 vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the company has received an additional order from the U.S. Department of Health and Human Services (HHS) to produce vaccine to help protect against the Influenza A (H1N1) 2009 virus. The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 mcg of antigen per dose.

22 Sep 2009

CDC recommends seasonal influenza vaccination to counter H1N1

Public health experts, including the Centers for Disease Control and Prevention (CDC), recommend seasonal influenza vaccination as the first line of defense this year in protecting against the influenza virus.

22 Sep 2009

PeriGen’s protocol bundle to prevent H1N1 in pregnant women

PeriGen, Inc., today announced the release of its Influenza Prevention and Treatment Bundle to its North American client hospitals. In advance of the approaching flu season, PeriGen’s protocol bundle will help clinicians follow recommended guidelines for screening, preventing and treating as well as accurately reporting cases of seasonal flu and H1N1 (“Swine Flu”) to state and local officials.

22 Sep 2009

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.

22 Sep 2009

U.S. hospital emergency departments not equipped to care for children

According to a recent IOM report, only 6 percent of U.S. hospital emergency departments are fully equipped to properly care for children. With high rates of novel H1N1 (swine) flu expected this winter, the time to address these deficiencies is immediate.

22 Sep 2009

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

22 Sep 2009

Bi-directional health information exchange to deal with disease outbreaks

Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.

22 Sep 2009

Update from Cannabis Science regarding its phytocannabinoid pharmaceutical products

Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report progress for its phytocannabinoid pharmaceutical products to help reduce ARDS-associated deaths from both the Avian and Swine Influenza infections.

22 Sep 2009

Duke University awarded $19.5M to design a portable viral infection detection device

The Defense Advanced Research Projects Agency (DARPA), the research arm of the U.S. Department of Defense, has awarded Duke University $19.5 million for an effort led by the Duke Institute for Genome Sciences & Policy (IGSP) to design a portable, easy-to-use diagnostic device that can reveal who is infected with an upper respiratory virus before the first cough or sneeze.

22 Sep 2009

U.N. report calls for $1.48B to help developing nations cope with H1N1

The U.N. this week will request that wealthy nations and development banks donate $1.48 billion to help developing countries fight H1N1 (swine flu), Bloomberg reports. "Most of the money is needed for vaccines and drugs … to help the least-developed nations cope with the influenza pandemic, according to a U.N. report obtained" Monday by the news service.

21 Sep 2009

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).

21 Sep 2009